Sequoia and First Round co-led the seed, Hummingbird Ventures led a $30M Series A, for AI that surfaces patients needing closer clinical attention.
Healthleap closed $38 million across an $8 million seed co-led by Sequoia Capital and First Round Capital, and a $30 million Series A led by Hummingbird Ventures. The company's AI flags hospital patients who may need closer monitoring, targeting a clinical workflow problem rather than a general-purpose model.
The stacked seed-to-Series-A raise in rapid succession points to investor confidence in healthcare-specific AI tools that integrate into existing hospital operations rather than require workflow overhauls.
Tier-one investors backing a narrow clinical-decision-support tool is a signal: healthcare AI is shifting from chatbot pilots to deployed, liability-bearing production systems. Hospital operators evaluating vendors should expect this category to consolidate fast as capital concentrates around teams that can prove clinical outcomes, not just demos.
The daily signal, curated. Get it in your inbox.
Subscribe on LinkedIn →